Clinical Research in Cardiology

Article	Citations
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry	89
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort	74
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial	62
Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery	61
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis	57
HI-PLUS: design of a cluster-randomized trial evaluating structured case management with telemonitoring to improve quality of life in heart failure	52
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	49
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	47
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy	47
Perioperative atrial fibrillation after non-cardiac surgery — A narrative review	45
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses	42
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results	40
Collagen type I degradation peptide as a predictive biomarker for mortality in ST-elevated myocardial infarction	39
Rebuttal to: “Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation.“ (CRCD-D-26–00099)	39
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection	38
Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion	37
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction	34
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction	33
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry	31
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study	30
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy	29
Venting during venoarterial extracorporeal membrane oxygenation	27
Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy	27
Echocardiographic assessment of left ventricular volumes: a comparison of different methods in athletes	26
Left ventricular ejection fraction determines the pattern of left atrial remodeling in patients with heart failure without atrial fibrillation	26

Appointment as Editor-in-Chief of Clinical Research in Cardiology—goals and vision	26
Non-specific myocardial fibrosis in young competitive athletes: clinical significance and risk prediction by a powerful machine learning-based model	25
Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization	25
DGK Herztage 2025	24
Outcomes after redo ablation for the recurrence of atrial fibrillation: a systematic review and meta-analysis	24
The relationship between serum potassium levels and cardiac arrhythmias in left ventricular assist device (LVAD) recipients: a comprehensive analysis and prognostic evaluation	24
Correction: The influence of lipoprotein(a) on aortic valve calcification in patients undergoing transcatheter aortic valve replacement	23
Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices	23
Frailty, periinterventional complications and outcome in patients undergoing percutaneous mitral and tricuspid valve repair	23
Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation	23
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndrome: a meta-analysis	22
Antithrombotic strategy following valve-in-valve transcatheter aortic valve replacement. A German Statutory Health Claims data analysis	21
Valve morphology and timing of surgery in bicuspid aortic valve disease	21
Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry	20
Time- and dose-dependent high-sensitivity cardiac troponin-T to improve outcome prediction after TAVI: a multicenter cohort study	20
Aortic regurgitation is associated with African American and Asian race, smoking, renal disease, and numerous autoimmune diseases in addition to traditional cardiovascular risk factors but has lower r	20
Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair	19
Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials	19
Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)	19
The effect of a smaller spacer in the PASCAL Ace on residual mitral valve orifice area	19
Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis	18
Long-term outcome of patients presenting with myocardial injury or myocardial infarction	18
Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison	18
Correction: Safety and feasibility of early discharge after transcatheter aortic valve implantation with ACURATE Neo—the POLESTAR trial	18
The pathophysiological approach: the best for phenotyping patients with pulmonary arterial hypertension: reply	17
Comment on: GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis	17
Response in renal function after transcatheter tricuspid edge-to-edge repair	17
Normal age- and sex-based values of right ventricular free wall and four-chamber longitudinal strain by speckle-tracking echocardiography: from the Copenhagen City heart study	17
Effects of sympathomodulation on pulse wave properties in heart failure with preserved ejection fraction	16
Spontaneous blood pressure reduction of previously hypertensive patients as a symptom of central pulmonary artery embolism	16
Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry	16
Characteristics and outcomes of angiovac-assisted debulking of intracardiac masses, thrombi, and endocarditis	16
Characterizing technical success and clinical outcomes in patients with pulmonary embolism treated with ultrasound-assisted catheter-directed thrombolysis (USAT): a retrospective, single-center cohort	16
Fluid balance during acute phase extracorporeal cardiopulmonary resuscitation and outcomes in OHCA patients: a retrospective multicenter cohort study	16
Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair	16
The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry	16
Ultrasound versus angiographic guided access in transfemoral TAVI: intra-operator evaluation of vascular and bleeding complications	16
Prognostic value of heart rate and oxygen pulse response in heart failure with left ventricular ejection fraction over 40%	16
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications	15
Arrhythmias and laboratory abnormalities after an electrical accident: a single-center, retrospective study of 333 cases	15
Quantitative flow ratio or angiography for the assessment of non-culprit lesions in acute coronary syndromes, a randomized trial	15
Optimal radial artery diameter for predicting radial artery occlusion after transradial coronary catheterization	15
Right ventricular to pulmonary artery coupling in patients with different types of aortic stenosis undergoing TAVI	15
A systematic review and meta-analysis of the use of drug-coated balloon angioplasty for treatment of both de novo and in-stent coronary chronic total occlusions	14
Comparison of left atrial appendage occlusion with medical treatment for non-valvular atrial fibrillation: systematic review, network and reconstructed individual patient data meta-analysis	14
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair	14
Targeted proteomic profiling of transcatheter edge-to-edge repair failure in patients with mitral regurgitation and heart failure	14
Duration of heart failure as a determinant of outcomes after left ventricular assist device implantation: an international multicenter study	14
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide	14
The ABC of sealing following left atrial appendage closure	14

Predicting atrial fibrillation after an acute coronary syndrome: insights from the BACS & BAMI study	14
The impact of myocardial injury on outcomes in TAVI patients	14
Comparison of contemporary transcatheter heart valve prostheses: data from the German Aortic Valve Registry (GARY)	14
Differential effects of transcatheter edge-to-edge repair on forward stroke volume in atrial and ventricular secondary mitral regurgitation	14
Infective endocarditis after isolated aortic valve replacement: comparison between catheter-interventional and surgical valve replacement	14
Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females	14
Cost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients—economic evaluation along a one-year observation period	14
NET burden in left atrial blood is associated with biomarkers of thrombosis and cardiac injury in patients with enlarged left atria	14
Validation of complex PCI criteria in drug-coated balloon angioplasty	13
Reply to “Comment on: GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis”	13
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment	13
New avenues for the assessment of stable ischemic heart disease	13
Endothelial activation and stress index (EASIX) in coronary artery disease: a simplified measure as a promising biomarker	13
Prognostic impact of body mass index in acute myocardial infarction complicated by cardiogenic Shock: an ECLS-SHOCK subanalysis	13
Sex-related presentation, outcome, and treatment in CICU: the SPOTlight STUDY	13
Global longitudinal strain in long-term risk prediction after acute coronary syndrome: an investigation of added prognostic value to ejection fraction	12
ACEF score and lactate: lifeline predictors in endocarditis valve procedures: insights from a single-center study	12
Left atrial appendage occlusion: trends in demographics and in-hospital outcomes—a German nationwide analysis	12
Evolving trends and persistent challenges in chronic left ventricular heart failure management: insights from a 9-year analysis of in-hospital outcomes in Germany	12
The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review	12
Blood pressure changes during tenofovir-based antiretroviral therapy among people living with HIV in Lilongwe, Malawi: results from the prospective LighTen Cohort Study	12
RAS inhibitors and renal and general mortality in patients with heart failure supported by left ventricular assist devices: a registry study	12
The weekend effect in atrial fibrillation hospitalizations: a nationwide analysis of outcomes and interventions	12
Comparative cardiovascular outcomes of GLP-1 receptor agonists vs. SGLT2 inhibitors in type 2 diabetes: a large-scale real-world cohort analysis	12
Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation	12
Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve: results from the multicenter TAXI registry	12
Mid- to long-term outcomes of covered balloon-expandable stent implantation for the management of vascular injuries in patients undergoing transfemoral transcatheter aortic valve implantation: the BE-	12
Computed tomography-derived Hounsfield units for the differentiation between thrombosis and leaflet fibrosis in bioprosthetic heart valves	12
Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR	12
Impact of residential noise pollution on early-onset myocardial infarction risk results from the DECIBEL-MI (Determination of Environmental CIty-noise's Burden, Exposure, and Link to Myocardial Infarc	12
Age period cohort analysis of rheumatic heart disease in high-income countries	12
Impact of left atrial appendage occlusion device position on potential determinants of device-related thrombus: a patient-specific in silico study	12
Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implications	12
Acute and long-term results of interventional treatment of paravalvular leaks after prosthetic valve replacement with plug devices: results from a prospective multicentre registry	12
Prognostic value of lipoprotein(a) in a primary prevention ambulatory cohort	12
Cardiac transthyretin amyloidosis in aortic valve replacement: RAISE score performance in the postoperative setting	12
Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation	11
Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure	11
Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI	11
Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND	11
Incidence and clinical impact of renal failure and bleeding following transcatheter tricuspid valve annuloplasty	11
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension	11
Five-year-outcome of new-onset perioperative atrial fibrillation after left atrial appendage amputation concomitant with cardiac surgery	11
Comparison of a novel self-expanding transcatheter heart valve with two established devices for treatment of degenerated surgical aortic bioprostheses	11
Long-term outcomes with medical therapy, transcatheter repair, or surgery for isolated tricuspid regurgitation: a systematic review and network meta-analysis	11
Effect of eplerenone in acute heart failure using a win ratio approach	11
Anti-inflammatory role of lipoprotein apheresis in the era of small interfering RNA inhibitor of apolipoprotein(a)	11
Publisher Correction: Respiratory exchange ratio overshoot during exercise recovery: a promising prognostic marker in HfrEF	11
Comparison of plug-based versus suture-based vascular closure for large-bore arterial access: a collaborative meta-analysis of observational and randomized studies	10
Impact of pre-existing CIED on mid-term mortality in patients undergoing TAVR	10
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany	10
Prior hospitalizations as a predictor of prognosis in heart failure with mildly reduced ejection fraction	10
Cocaine-induced acute myocardial infarction: angiographic features and outcomes	10
Comparison of Arctic Front Advance Pro and POLARx cryoballoons for ablation therapy of atrial fibrillation: an intraprocedural analysis	10
LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry	10
New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis	10
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART)	10
Causal association between lipoproteins and risk of coronary artery disease—a systematic review and meta-analysis of Mendelian randomization studies	10
Tpeak-Tend interval predicts VT inducibility in arrhythmogenic mitral valve prolapse syndrome	10
Myocardial work in chronic kidney disease: insights from the CPH-CKD ECHO Study	10
Towards automatic classification of cardiovascular magnetic resonance Task Force Criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy	10
Safety and feasibility of early discharge after transcatheter aortic valve implantation with ACURATE Neo—the POLESTAR trial	10
DCB therapy: quo vadis?	10
Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials	10
Atherosclerosis is an inflammatory disease: treat it as such!	10
Sex-related hormonal variances and clinical outcomes in TAVR patients	10
Investigating procedural safety: comparative analysis of rotational atherectomy and modified balloon angioplasty	10
Editorial comment: echocardiography in atrial fibrillation: overcoming challenges and embracing innovations	9
Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk	9
Risk and effect modifiers for poor glycemic control among the chinese diabetic adults on statin therapy: the kailuan study	9
Pericapsular nerve group block reduces fentanyl use in transcatheter aortic valve implantation: a randomized prospective study	9
A novel score to predict in-hospital mortality for patients with acute coronary syndrome and out-of-hospital cardiac arrest: the FACTOR study	9
Genetic and modifiable risk factors combine multiplicatively in common disease	9
Absence of chest discomfort in type 1 NSTEMI patients: predictors and impact on outcome	9
Sex differences in guideline adherence for coronary angiography in patients with suspected chronic coronary syndrome in Germany: insights from the ENLIGHT-KHK trial	9
Correction: Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial	9
Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis	9
Right ventricular function and dimensions in patients undergoing transcatheter aortic valve replacement assessed by three-dimensional echocardiography	9
Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis	9
Effect of vessel diameter on the clinical benefits of drug-coated balloon angioplasty: Insights from paclitaxel-coated balloon and polymer-free sirolimus-eluting stent studies	9

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination	8
PFO in pregnancy: amniotic fluid embolism complicated by paradoxical embolism	8
Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation	8
Erythropoietic response to oral iron with sodium-glucose co-transporter 2 inhibitors	8
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists	8
Balloon technologies for pulmonary vein isolation—12-month outcome and comparison of the novel radiofrequency balloon with the cryoballoon in patients with paroxysmal atrial fibrillation	8
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications	8
Comment on Grundmann et al. “Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI”	8
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study	8
The role of cardiac magnetic resonance in sports cardiology: results from a large cohort of athletes	8
Differences in clinical features and 1-year outcomes of patients with heart failure and reduced, mildly reduced, and preserved ejection fraction in a contemporary cohort: is the clinical profile chang	8
Correction: Critical insights on association of aortic root diameter and vascular function with an exaggerated blood pressure response to exercise among elite athletes	8
Cardiac sarcoidosis in patients with recurrent ventricular arrhythmias refractory to endocardial ablation	8
Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function	8
Short- and long-term outcomes of patients with active cancer presenting with an acute coronary syndrome	8
Treatment of patients with multiple organ dysfunction syndrome (MODS) with an electromagnetic field coupled to biorhythmically defined impulse configuration: the MicrocircMODS study	8
Letter to the editor: reply	8
Microvascular dysfunction and heart failure with preserved ejection fraction	8
Personalized diagnosis in suspected myocardial infarction	8
Interaction between coronary lesion complexity and coronary microvascular dysfunction in the prognosis of NSTEMI patients	8
Sex-specific differences in disease severity and outcomes in left ventricular heart failure: a nationwide cohort study	8
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the ra	8
Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy	8
Impact of serum potassium levels on success of electrical cardioversion in atrial fibrillation	8
A 39-year-old women with newly diagnosed ALCAPA syndrome during pregnancy	8
Angiography-derived physiological patterns of coronary artery disease: implications with post-stenting physiology and long-term clinical outcomes	8
Transient thrombocytopenia following transcatheter tricuspid valve interventions	8
Sex-specific influence of Lipoprotein(a) levels on coronary plaque characteristics: - The COPRODUCTION Registry -	8
Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure	8
German Cardiac Arrest Registry (G-CAR)—results of the pilot phase	8
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization	8
GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromes	7
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients	7
Successful baroreflex activation therapy in a case of therapy-resistant renovascular hypertension	7
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany	7
Cumulative incidence and risk factors of myocardial infarction during 20 years of follow-up: comparing two cohorts of middle-aged men born 30 years apart	7
Letter to the editor: “Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease”	7
Correction to: The Zwolle experience with left bundle branch area pacing using stylet-driven active fixation leads	7
Comparison of long-term outcome in patients with in-stent restenosis treated with intravascular lithotripsy or with modified balloon angioplasty	7
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study	7
Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock	7
Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study	7
Absorb® bioresorbable scaffold in “established” versus “off-label” coronary lesions: 5-year data from the GABI-R® registry	7
Bedside echocardiography in patients with suspected acute myocardial infarction without ST elevation	7
Metabolically ‘extremely unhealthy’ obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study	7
Comparison of therapeutic strategies in patients presenting with left atrial thrombus despite oral anticoagulation	7
LipidSnapshot – Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented by office-based cardiologists and general practitioners in Germany	7
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany	7
Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial	7
Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis	7
EASIX as a predictor of 3-year mortality in aortic stenosis patients undergoing TAVR	7
Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement	7
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study	7
VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients	7
One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and	7
AI-assisted computed tomography analysis for pre-procedural planning prior to TAVI	7
Interhospital transfer versus direct admission for percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a systematic review and meta-analysis	7
Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany	7
Differential effects of anaemia and iron deficiency on long-term outcomes following transcatheter edge-to-edge repair in degenerative vs. secondary mitral regurgitation: results from a large single-ce	7
Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design	7
Response to the Letter to the editor: “cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease” (CRCD-D-24–01694)	7
Healthcare resource utilisation and associated costs after low-risk pulmonary embolism: pre-specified analysis of the Home Treatment of Pulmonary Embolism (HoT-PE) study	7
Comparison of transcatheter leaflet-approximation and direct annuloplasty in tricuspid regurgitation	6
Statins for primary prevention of cardiovascular disease in Germany: benefits and costs	6
Determinants and reference values of the 6-min walk distance in the general population—results of the population-based STAAB cohort study	6
Mitral annular disjunction in out-of-hospital cardiac arrest patients—a retrospective cardiac MRI study	6
Impact of GLP-1 receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis	6
Performance of wearable watch-type home blood pressure measurement devices in a real-world clinical sample	6
Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement	6
Myocardial strain shows modest diagnostic yield but may aid identification of patients with a low likelihood of ischemia during vasodilator stress cardiac magnetic resonance	6
Invasive transvalvular flow rate to predict likely severe aortic valve stenosis with low-gradient and normal ejection fraction	6
Neurocognition and health-related quality of life in patients randomized to surgical or transcatheter aortic-valve replacement	6
Discussion of hemodynamic optimization strategies and the canonical understanding of hemodynamics during biventricular mechanical support in cardiogenic shock: does the flow balance make the differenc	6
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial	6
Thrombotic ST-segment elevation myocardial infarction caused by a caseous mitral annular calcification	6
Epicardial ventricular tachycardia ablation: safety and efficacy of access and ablation using low-iodine content	6
Covert macrovascular disease and early outcome after ischemic cerebrovascular events	6
Age- and sex-based normal reference ranges of the cardiac time intervals: the Copenhagen City Heart Study	6
Impact of catheter ablation on prognostic outcomes in electrical storm	6
Sex differences of sequential changes in coronary blood flow and microvascular function in patients with suspected angina	6
Improving outcomes of AF ablation by integrated personalized lifestyle interventions: rationale and design of the prevention to improve outcomes of PVI (POP) trial	6
Is takotsubo syndrome probably an acute coronary syndrome after all?	6
Feasibility and outcome of third-generation transcatheter aortic valve implantation in patients with extra-large aortic annulus	6
Impact of common rhythm disturbances on echocardiographic measurements and interpretation	6
Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy	6
Association between three-year mortality after transcatheter aortic valve implantation and paravalvular regurgitation graded by videodensitometry in comparison with visual grading	6
Respiratory exchange ratio overshoot during exercise recovery: a promising prognostic marker in HFrEF	6
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors	6
Feasibility, timing and outcome of leadless cardiac pacemaker implantation in patients undergoing cardiac implantable electronic device extraction	6
High residual gradients after transcatheter aortic valve implantation in raphe-type bicuspid aortic valve stenosis: insights from the AD-HOC registry	6
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial	6
Reply to the Letter to the Editor, regarding the article "German Cardiac Arrest Registry: rationale and design of G-CAR"	6